Immuron (ASX:IMC) - CEO, Steven Lydeamore
CEO, Steven Lydeamore
Source: Immuron
Market Herald logo

Subscribe

Be the first with the news that moves the market
  • Biopharmaceutical company Immuron (IMC) sees a 494 per cent increase in North American Travelan sales for FY22
  • Sales totalled $600,000 for the financial year, up from the $100,000 recorded in FY21 while US sales were up from the $4000 recorded in FY21
  • Global sales of Travelan and Protectyn – a supplement that targets and removes bacteria in the gut – increased 431 per cent from $200,000 in FY21 to $900,000 in FY22
  • Notably in Australia, Travelan and Protectyn sales increased to $300,000 in FY22 from $100,000 in FY21
  • Shares in Immuron ended the day 3.41 per cent in the green to close at 9.1 cents

Biopharmaceutical company Immuron (IMC) has seen a 494 per cent increase in North American Travelan sales for FY22.

Sales totalled $600,000 for the financial year, up from the $100,000 recorded in FY21 while US sales were up from the $4000 recorded in FY21.

Immuron credits this growth to increasing sales in passport health travel clinics as well as on Amazon’s e-commerce channel.

While sales are currently not at their pre-pandemic peak, sales in the US are starting to pick up.

Travelan is an orally administered passive immunotherapy that reduces the likelihood of contracting travellers’ diarrhoea when visiting developing countries.

Global sales of Travelan and Protectyn – a supplement that targets and removes harmful bacteria and toxins in the gut – increased 431 per cent from $200,000 in FY21 to $900,000 in FY22.

Notably in Australia, Travelan and Protectyn sales increased to $300,000 in FY22 from $100,000 in FY21.

After coming out of Government-imposed restrictions and international travel resuming, retail stores in Australia are beginning to restock the products.

Shares in Immuron ended the day 3.41 per cent in the green to close at 9.1 cents.

IMC by the numbers
More From The Market Herald

" Metgasco (ASX:MEL) flags $5.9m buyout of Patriot Hydrogen

Metgasco (ASX:MEL) is set to purchase waste-to-hydrogen production business Patriot Hydrogen for $5.9 million as part…
Horizon Minerals (ASX:HRZ) - Managing Director, Jon Price

" Horizon Minerals (ASX:HRZ) gets “excellent” drill results at Monument, WA

Horizon Minerals (ASX:HRZ) reports "excellent" results from the Monument gold prospect in WA.

" Emyria (ASX:EMD) launches phase 3 EMD-RX5 trial

Emyria (ASX:EMD) has launched its phase three clinical trial of its ultra-pure CBD candidate.

" New Age Exploration (ASX:NAE) granted Marlborough project, NZ

New Age Exploration (ASX:NAE) is granted a prospecting permit which covers the Marlborough gold project in…